Clinical trial · Observational
A Pilot Study to Evaluate Optical Spectroscopy of Pigmented Skin Lesions
A Pilot Study to Evaluate the Correlation Between Modified Two Layer Diffuse Optical Spectroscopy With the Clinical and Histological Examinations of Pigmented Skin Lesions Based on Physiological Parameters
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The incidence of malignant melanoma has increased dramatically in recent decades. In 1930, the lifetime risk of an individual in the United States developing melanoma was 1 in 1,500. This has been exponentially increasing over the years with the risk estimated to be 1 in 75 in 2000 . According to the American Cancer Society, approximately 59,580 new cases of melanoma will be diagnosed in the United States in 2005 and about 7,770 people are expected to die of the disease.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer | Malignant Skin Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Optical Spectroscopy | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Medical tool
- description
- Optical Spectroscopy imaging are Modified Two Layer Diffuse Optical Spectroscopy and multi-spectral imaging and Spatially Modulated Quantitative Spectroscopy
- interventionNames
- Device: Optical Spectroscopy
Primary outcomes (1)
- measure
- Measure atypical moles and melanoma
- timeFrame
- 4 weeks
- description
- Optical Spectroscopy imaging of atypical moles and melanoma to correlate results from the results of the biopsy tissue histology
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * 18 years or older. * Have atypical mole/s and melanoma Exclusion Criteria: * Age less than 18 years old. * have NO atypical mole/s and melanoma
References
Publications (0)
Data not yet available